SUPPRELIN® LA: Support Center

Health care plans, insurance coverage, co-pays, and the process for reimbursement can be complex.

The SUPPRELIN LA Support Center works on the patient's behalf to organize and coordinate the services patients need to initiate SUPPRELIN LA.

To begin the treatment process:

  1. Be sure to read the Support Center Brochure before calling 1-855-270-0123 as it is the first step to enrolling with the SUPPRELIN LA Support Center.

    Support Center Brochure

  2. If you have agreed that SUPPRELIN LA is your child's treatment option, enroll in the SUPPRELIN LA Support Center by returning the Patient Authorization Form.

    Patient Authorization Form

 

Your SUPPRELIN LA Support Center representative will contact you by telephone within 24 hours of receiving your Patient Authorization Form to explain the services that the Support Center offers.

Please download the Service Request Enrollment Form, which must be completed by your healthcare provider, for all requests of assistance.

If you have any questions at any time, you can call 1-855-270-0123.

NEXT: Frequently Asked Questions

Indication

SUPPRELIN® LA (histrelin acetate) subcutaneous implant is used for the treatment of children with central precocious puberty (CPP).

Important Safety Information

  • SUPPRELIN LA should not be used by women who are or may become pregnant, and in patients who are allergic to gonadotropin releasing hormone (GnRH) or GnRH agonist analogs. Safety and effectiveness in children under 2 years of age has not been determined.

  • SUPPRELIN LA, like other GnRH agonists, may cause a temporary increase in the blood levels of specific hormones associated with the onset of puberty (estrogen in girls and testosterone in both sexes) during the first week of treatment. This increase may temporarily worsen puberty symptoms during the first week, additionally, you may see new symptoms appear during this period. Within the 4 weeks of treatment with SUPPRELIN LA, hormonal suppression generally occurs and the physical signs of puberty should decrease.

  • Your doctor should monitor the levels of specific hormones associated with puberty progression, 1 month after starting SUPPRELIN LA and then every 6 months thereafter. Every 6-12 months, height and bone age should be also monitored by your doctor.

  • During the clinical trial testing of SUPPRELIN LA, the most common side effects involved the implant site and included temporary bruising, pain, soreness, redness of the skin and swelling.

Please talk with your doctor for more information or if you have any questions.